Online Only - Pharmaceutical Executive


Online Only

Listen to a preview of Drugs, Devices or Data - Which is Most Valuable? Webcast

October 15, 2009

Bio Companies Low on Venture Capital Cash

May 6, 2009

As the economy continues to retract, fewer biotech companies are finding the funding they need to survive, driving more firms to sell or close shop.

Pharma Steps Up to Help With Swine Flu

April 29, 2009

As the US government weighs its options on whether to commission a vaccine for the new H1N1 strain of influenza, pharma companies gear up for a possible epidemic.

Higher Learning for Pharma Sales Reps

April 29, 2009

American Society of Hypertension to launch new education program that grants sales reps hypertension accreditation after rigorous training.

Ortho-McNeil Launches Facebook Site for Adult ADHD

April 29, 2009

Ortho-McNeil is reaching out to the adult ADHD segment through the popular social networking site. The plan is to grow followers through education and unbranded information. Pharm Exec takes a look at the new site.

Pfizer and Glaxo Join Forces in HIV Venture

April 22, 2009

The two pharma giants announced plans to form a new specialty company focused on HIV drug development. The new, independent firm will have a total of 11 drugs on the market, with another six on the horizon, securing its place as a powerhouse in the HIV market.

US Pharma Market To Decline in 2009

April 22, 2009

IMS has revised its 2009, forecast and the outlook isn't pretty for the United States, which looks to drop 1 to 2 percent in the coming year.

GSK Grabs Derma Firm for $2.9 Billion

April 22, 2009

Stiefel Labs is under new management. The dermatology company was purchased by GSK in an effort to bolster its existing skincare line.

J&J Eliminates 900 Sales Positions

April 15, 2009

In an effort to realign its sales division to reflect the current pharma environment—smaller, faster, better—Johnson & Johnson is trimming its sales force.


Click here